Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Serum DCAMKL1 Pre and Post Treatment in Patients With Pancreatic Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
University of Oklahoma
ClinicalTrials.gov Identifier:
NCT01580241
First received: April 17, 2012
Last updated: December 2, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2015
  Estimated Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)